Cyclooxygenase-2 expression during carcinogenesis in the human stomach

Journal of Pathology

Volumn 196, Issue 2, 2002, Pages 171-179

  Van Rees, Bastiaan P ^a,d   Saukkonen, Kirsi ^a,b   Ristimki, Ari ^a,b   Polkowski, Wojciech ^a   Tytgat, Guido N J ^a,b   Drillenburg, Paul ^a,b   Johan A Offerhaus, G ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Lublin Medical Academy   (Poland)

Author keywords

Cancer; Carcinogenesis; Cyclooxygenase; Stomach; Tumour progression

Indexed keywords

ALPHA ACTIN; CD68 ANTIGEN; CYCLOOXYGENASE 2; HLA DR ANTIGEN; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; VIMENTIN;

ARTICLE; CANCER GROWTH; CANCER RISK; CELL COMPARTMENTALIZATION; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG TARGETING; DRUG USE; EPITHELIUM CELL; GASTRECTOMY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH STUMP CARCINOMA; STROMA CELL;

ADENOCARCINOMA; CHI-SQUARE DISTRIBUTION; CYCLOOXYGENASE 2; CYTOPLASM; GASTRIC STUMP; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; ISOENZYMES; MEMBRANE PROTEINS; PRECANCEROUS CONDITIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; STOMACH NEOPLASMS;

EID: 0036156229     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1033     Document Type: Article

References (42)

1. NSAID use and decreased risk of gastrointestinal cancers
2. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
3. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
4. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
5. Cyclooxygenase-2 inhibitors in tumorigenesis
6. The role of cyclooxygenases in inflammation, cancer, and development
7. The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs)
8. Chemoprevention of colorectal cancer
9. Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract
10. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
11. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis
12. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
13. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure
14. The two main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinomas: An attempt at a histoclinical classification
15. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal type gastric adenocarcinoma
16. Mortality from gastric cancer following gastric surgery for peptic ulcer
17. The mucosa of the gastric remnant harboring malignancy. Histologic findings in the biopsy specimens of 504 asymptomatic patients 15 to 46 years after partial gastrectomy with emphasis on nonmalignant lesions
18. Gastric stump cancer: Lessons from old specimens
19. Evaluation of endoscopy for early detection of gastric-stump cancer
20. Expression of cyclooxygenase-2 in human gastric carcinoma
21. Induction of cyclooxygenase-2 by interleukin-1 alpha. Evidence for post-transcriptional regulation
22. Expression of cyclooxygenase-2 protein in gastric adenocarcinoma
23. Cyclooxygenase-2 over-expression enhances lymphatic invasion and metastasis in human gastric carcinoma
24. Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions
25. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma
26. Cell proliferation kinetics in the gastric remnant
27. Aspirin protects against gastric cancer: Results of a case-control study from Moscow, Russia
28. Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus
29. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis
30. Localisation of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissues in humans
31. Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa
32. Host cyclooxygenase-2 modulates carcinoma growth
33. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells
34. 2 increases growth and motility of colorectal carcinoma cells
35. Influence of oral 15(R)-15-methyl prostaglandin E2 on human gastric mucosa. A light microscopic, cell kinetic, and ultrastructural study
36. Inhibition of cyclooxygenase-2 gene expression by p53
37. Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
38. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
39. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10(-/-) mice
40. COX-2 in murine intestinal tumors
41. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice
42. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma